Effect of Motor Nerve Block on Muscle Stiffness of Overactive Muscles
Study Details
Study Description
Brief Summary
Objective:
-
to investigate the effect of a supraselective motor nerve block (MNB), by the means of local anesthesics injection, on the different components of muscle stiffness of overactive upper and/or lower limb muscles in patients with brain injury
-
to investigate the relationship between muscle stiffness measured by shearwave elastography (SWE) and by MyotonPro
-
to investigate the correlation between muscle stiffness measured by SWE and clinical outcomes
Methods: each patient will be given selective diagnostic motor nerve block. All patients will be evaluated 1 hour before and 1 hour after the MNB.
Outcomes: muscle stiffness measured by sonoelastography and MyotonPro; clinical evaluation (passive range of motion, modified ashworth scale, tardieu scale, fuglmeyer) Hypothesis: MNB will decrease muscle stiffness measured by SWE. The results of SWE will be correlated with the results of MyotonPro and with clinical outcomes.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- change of muscle stiffness measured with shearwave elastography (SWE) [same day: 1hour before and 1hour after BMN]
expressed in m/s. A smaller shearwave velocity indicates a better outcome
Secondary Outcome Measures
- change of muscle stiffness assessment with MyotonPro [same day: 1hour before and 1hour after BMN]
a smaller muscle stiffness indicates a better outcome
Other Outcome Measures
- change of passive range of motion [same day: 1hour before and 1hour after BMN]
expressed in angles °. The greater the angle, the better the outcome
- change of modified ashworth scale [same day: 1hour before and 1hour after BMN]
minimum score:0; maximum score: 4. A higher score indicates a greater spasticity thus a worse outcome
- change of Tardieu scale [same day: 1hour before and 1hour after BMN]
minimum score:0; maximum score: 4. A higher score indicates a greater spasticity thus a wourse outcome
- change of Fugl-meyer score [same day: 1hour before and 1hour after BMN]
maximum score of 100. The highest the score, the better the motor function
Eligibility Criteria
Criteria
Inclusion Criteria:
-
age > 18 years
-
hemiparesia/-plegia following brain injury (TBI, stroke,...)
-
3 months after brain injury
-
muscle overactivity in upper and/or lower limb requiring injection of botulinum toxin thus a diagnostic MNB before (best clinical practice)
Exclusion Criteria:
-
other neurological or orthopaedic conditions involving the affected limb
-
aphasia or major cognitive impairment limiting functional assessment
-
botulinum toxin injection in the last 3 months
-
previous treatment of muscle overactivity with surgical procedures.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cliniques Universitaires Saint-Luc | Brussels | Belgium | 1200 |
Sponsors and Collaborators
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
- Principal Investigator: Gaëtan Stoquart, MD, PhD, Cliniques universitaires Saint-Luc
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2018/18MAI/217